Article in American journal of physiology. Cell physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Kalidas RamamoorthyDepartment of Physiology/Biophysics, School of Medicine, University of California, Irvine, California, United States.
Subrata SabuiDepartment of Physiology/Biophysics, School of Medicine, University of California, Irvine, California, United States.
George KimDepartment of Physiology/Biophysics, School of Medicine, University of California, Irvine, California, United States.
James M FlekensteinDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States.
Alaullah SheikhDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States.ORCID 0000-0002-2972-6978
Hamid M SaidDepartment of Physiology/Biophysics, School of Medicine, University of California, Irvine, California, United States.ORCID 0000-0003-1016-8547
Funding
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Jeffrey Wade Brown · 2000 to 2026
$30.8M
Novel Antigen Identification for an Enterotoxigenic E. coli VaccineR01AI089894 · NIAID · WASHINGTON UNIVERSITY · PI Zachary T. Berndsen, James Michael Fleckenstein · 2010 to 2026
$7.4M
Physiology/Pathophysiology of Vitamin B1 Transport in Pancreatic Acinar CellsR01AA018071 · NIAAA · UNIVERSITY OF CALIFORNIA-IRVINE · PI SAID, HAMID M · 2009 to 2023
$6.3M
Vitamin B1 (thiamin) transport in Alzheimer’s Disease: Role of microRNAs in regulating level of expression of its transporters (SLC19A2 & SLC19A3) in human brain cells and effect of hypoxiaR01DK056061 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI SAID, HAMID M · 1999 to 2024
$5.0M
Mechanism/Regulation of Intestinal Thiamin UptakeR37DK056061 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI SAID, HAMID M · 2009 to 2018
$3.6M
Molecular Pathogenesis of enterotoxigenic E. coli associated enteropathyR01AI170949 · NIAID · WASHINGTON UNIVERSITY · PI James Michael Fleckenstein · 2023 to 2026
$2.4M
Human Endogenous retroviruses as potential early markers for Alzheimer's diseaseR01CA226570 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI RAHMATPANAH, FARAH BAKHSHIAN · 2019 to 2023
$2.2M
2010 AUA/SBUR Summer Research ConferenceR13DK089894 · NIDDK · AMERICAN UROLOGICAL ASSOCIATION · PI WINTERS, JACK CHRISTIAN · 2010 to 2010
$15k
BLRD VA I01 BX001142BLRD VA I01 BX001469BLRD VA IK6 BX006189HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) AA018071HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) AA-018071S1HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) AI089894HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) AI170949HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) DK56061NCI NIH HHS R01 CA226570NIAAA NIH HHS R01 AA018071NIAID NIH HHS R01 AI089894NIAID NIH HHS R01 AI170949NIDDK NIH HHS P30 DK052574NIDDK NIH HHS R01 DK056061NIDDK NIH HHS R37 DK056061U.S. Department of Veterans Affairs (VA) 5I01BX001469-05U.S. Department of Veterans Affairs (VA) I01BX001142U.S. Department of Veterans Affairs (VA) IK6BX006189
6 · The paper itself
Abstract
The human colonic thiamin pyrophosphate transporter (hcTPPT) mediates the uptake of the microbiota-generated and phosphorylated form of vitamin B
Indexed as
Colonras GTPase-Activating ProteinsHumansMembrane Transport ProteinsProtein BindingThiamine PyrophosphateMembrane Transport Proteinsras GTPase-Activating ProteinsSLC44A4 protein, humanThiamine Pyrophosphateaccessory proteinscolonic uptakehuman colonocytesIQGAP-2thiamin pyrophosphate
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
IQGAP-2: a novel interacting partner with the human colonic thiamin pyrophosphate transporter. · full record | OpenQuestion